Image

Global Post-Traumatic Stress Disorder (PTSD) Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Jan 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Jan 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Post-Traumatic Stress Disorder (PTSD) Market By Product (Antidepressants, Cognitive Therapy, Anti-Anxiety Drugs, Exposure Therapy, Eye Movement Desensitization And Reprocessing (EMDR) and PSTD therapeutics), Application (Children and Adult), End Use (Hospitals and Clinics), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Global Post-Traumatic Stress Disorder (PTSD) Market Market Analysis and Insights of Global Post-Traumatic Stress Disorder (PTSD) Market

Global post-traumatic stress disorder (PTSD) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 7,452.9 million by 2028 growing at a CAGR of 4.14% in the above-mentioned forecast period. The growing prevalence of PTSD and rise in clinical trials has been directly impacting the growth of post-traumatic stress disorder (PTSD) market.

Post-Traumatic Stress Disorder (PTSD) is a problem that occurs when a person experiences life-threatening events such as terrorist incidents, natural disasters, serious accidents, military combat or sexual assault in adult or childhood. Most survivors of post-traumatic stress disorder return to normal conditions in a given time. However, some patients also experience stress reactions which continue for a longer period of time. Patients who suffer from have PTSD often remember their experiences through flashbacks or nightmares. They may have difficulties in many aspects of life which can include; feeling detached as these symptoms can be severe enough and might last long enough to affect the person’s daily life significantly.

Increasing cases of cross-border tensions, accidents, natural disasters, military combat and terrorist attacks is a key factor in driving the post-traumatic stress disorder (PTSD) market. Increasing sexual assault cases and rehabilitation programs for injured military personnel are also a driving factor for the market. The rise in the number of emerging therapies for PTSD and new medications to manage the symptoms of post-traumatic stress disorder is an opportunity for the post-traumatic stress disorder (PTSD) market.

Lack of awareness of post-traumatic stress disorder is the main challenge for the post-traumatic stress disorder (PTSD) market. However, high prices of treatment and side effects of specified medicine is the main restraint in the growth of post-traumatic stress disorder (PTSD) market during the forecast period of 2021-2028.

This post-traumatic stress disorder (PTSD) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research post-traumatic stress disorder (PTSD) market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Lilly is developing a growing portfolio of first-class and high-quality products through pharmaceuticals through the latest research conducted in its global laboratories and in collaboration with prominent scientific organizations. Lack of awareness of post-traumatic stress disorder is a challenging factor in the post-traumatic stress disorder (PTSD) market. However, the high cost and side effects of certain drugs are a major obstacle to the growth of post-traumatic stress disorder (PTSD) during the forecast period.

Post-Traumatic Stress Disorder (PTSD) Market Scope and Market Size

Post-traumatic stress disorder (PTSD) market is segmented on the basis of product, end-use and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on product, the post-traumatic stress disorder (PTSD) market is segmented into antidepressants, cognitive therapy, anti-anxiety drugs, exposure therapy, eye movement desensitization and reprocessing (EMDR) and PSTD therapeutics. Antidepressants is further sub-segmented into SSRIs, SNRIs, MAO inhibitors and tricyclic antidepressants. Anti-anxiety drugs is further sub-segmented into beta-blockers and benzodiazepines.
  • Based on application, the post-traumatic stress disorder (PTSD) market is segmented into children and adult.
  • Based on end use, the post-traumatic stress disorder (PTSD) market is segmented into hospitals and clinics.

Post-Traumatic Stress Disorder (PTSD) Market Country Level Analysis

Post-traumatic stress disorder (PTSD) market is analysed and market size insights and trends are provided by country, product, end-use and application as referenced above.

The countries covered in the post-traumatic stress disorder (PTSD) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is likely to lead the post-traumatic stress disorder (PTSD) market. The regional market has been driven by the rise in awareness of post-traumatic stress disorder. However, many traumatic cases associated with PTSD are rape, childhood neglect, physical attack, combat exposure, sexual molestation, and childhood physical abuse which is the main factor propelling the growth of the regional market. The market in Asia-Pacific is expected to exhibit a substantial growth rate during the forecast period 2021-2028 due to rise in accident cases in this region.

The country section of the post-traumatic stress disorder (PTSD) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Post-traumatic stress disorder (PTSD) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for post-traumatic stress disorder (PTSD) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the post-traumatic stress disorder (PTSD) market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Post-Traumatic Stress Disorder (PTSD) Market Share Analysis

Post-traumatic stress disorder (PTSD) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related post-traumatic stress disorder (PTSD) market.

The major players covered in the post-traumatic stress disorder (PTSD) market report are GlaxoSmithKline plc., Pfizer Inc., Eli Lilly and Company, H. Lundbeck A/S, Azevan Pharmaceuticals, Inc., Marinus Pharmaceuticals, Inc., Tonix Pharmaceuticals Holding Corp., Bionomics, Greenstone LLC, Mylan NV, Otsuka Pharmaceutical Co., Ltd, Prometheon Pharma, LLC., Ligand Pharmaceuticals Incorporated, Lycera, JSC Valenta Pharm., ICH GCP., Nuvo Pharmaceuticals Inc., Zhenxiang Electromechanical Technology (Shanghai) Co., Ltd., AstraZeneca, Neurocrine Biosciences Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-
Why Choose Us


Frequently Asked Questions

Post-Traumatic Stress Disorder (PTSD) Market is growing at a CAGR of 4.14% during the forecast period of 2021 to 2028.
Post-Traumatic Stress Disorder (PTSD) Market is expected to reach USD 7,452.9 million during the forecast period of 2021 to 2028
Global Post-Traumatic Stress Disorder (PTSD) Market segmented By Product such as Antidepressants, Cognitive Therapy, Anti-Anxiety Drugs, Exposure Therapy, Eye Movement Desensitization And Reprocessing (EMDR) and PSTD therapeutics.
The major players covered in the post-traumatic stress disorder (PTSD) market report are GlaxoSmithKline plc., Pfizer Inc., Eli Lilly and Company, H. Lundbeck A/S, Azevan Pharmaceuticals, Inc., Marinus Pharmaceuticals, Inc., Tonix Pharmaceuticals Holding Corp., Bionomics, Greenstone LLC, Mylan NV, Otsuka Pharmaceutical Co., Ltd, Prometheon Pharma, LLC., Ligand Pharmaceuticals Incorporated, Lycera, JSC Valenta Pharm., ICH GCP., Nuvo Pharmaceuticals Inc., Zhenxiang Electromechanical Technology (Shanghai) Co., Ltd., AstraZeneca, Neurocrine Biosciences Inc., among other domestic and global players.